Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARQULE INC | 320,000 | reported | 04 Oct 2007 | tx 21+1,565,000−1,115,000 |
| Cellectar Biosciences, Inc. | 50,000 | reported | 24 Jun 2020 | tx 16+169,800−992 |
| Lipocine Inc. | 7,500 | reported | 16 Dec 2020 | tx 13+123,500−3,750 |
| GYRE THERAPEUTICS, INC. | 1,190 | reported | 06 Sept 2018 | tx 19+839,250−33,936 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Dec 2020 | EXERCISE | Lipocine Inc. | 7,500 | 0.00 USD | |
| 16 Dec 2020 | EXERCISE | Lipocine Inc. | 7,500 | 0.00 USD | deriv |
| 24 Jun 2020 | GRANT_AWARD | Cellectar Biosciences, Inc. | 50,000 | 0.00 USD | deriv |
| 10 Jun 2020 | GRANT_AWARD | Lipocine Inc. | 22,000 | 0.96 USD | deriv |
| 04 Jun 2020 | PURCHASE | Cellectar Biosciences, Inc. | 18,000 | 1.08 USD | first after silence |
| 13 Jun 2019 | GRANT_AWARD | Cellectar Biosciences, Inc. | 6,500 | 0.00 USD | deriv |
| 12 Jun 2019 | GRANT_AWARD | Lipocine Inc. | 10,000 | 1.68 USD | deriv |
| 29 Nov 2018 | SALE | Cellectar Biosciences, Inc. | 53 | 2.21 USD | |
| 29 Nov 2018 | SALE | Cellectar Biosciences, Inc. | 939 | 2.21 USD | |
| 29 Nov 2018 | SALE | Cellectar Biosciences, Inc. | 9,390 | 0.10 USD | deriv |
| 29 Nov 2018 | SALE | Cellectar Biosciences, Inc. | 530 | 0.05 USD | deriv |
| 12 Oct 2018 | GRANT_AWARD | Cellectar Biosciences, Inc. | 13,000 | 0.00 USD | deriv |
| 06 Sept 2018 | OTHER | GYRE THERAPEUTICS, INC. | 190 | 10.07 USD | |
| 27 Jun 2018 | GRANT_AWARD | Lipocine Inc. | 20,000 | 1.33 USD | deriv |
| 13 Jun 2018 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 5,000 | 0.00 USD | deriv |
| 20 Feb 2018 | OTHER | GYRE THERAPEUTICS, INC. | — | 0.00 USD | deriv |
| 20 Feb 2018 | OTHER | GYRE THERAPEUTICS, INC. | 21,600 | 0.00 USD | deriv |
| 29 Dec 2017 | EXERCISE | Lipocine Inc. | 2,500 | 0.00 USD | |
| 29 Dec 2017 | SALE | Lipocine Inc. | 1,250 | 3.47 USD | |
| 29 Dec 2017 | EXERCISE | Lipocine Inc. | 2,500 | 0.00 USD | deriv |
| 13 Jul 2017 | GRANT_AWARD | GYRE THERAPEUTICS, INC. | 10,000 | 0.00 USD | deriv |
| 31 May 2017 | GRANT_AWARD | Cellectar Biosciences, Inc. | 10,000 | 0.00 USD | deriv |
| 26 Jan 2017 | GRANT_AWARD | Lipocine Inc. | 10,000 | 0.00 USD | deriv |
| 05 Jul 2016 | GRANT_AWARD | Cellectar Biosciences, Inc. | 22,500 | 0.01 USD | deriv |
| 14 Jun 2016 | GRANT_AWARD | Lipocine Inc. | 10,000 | 8.02 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 04 Jun 2020.